logo
15:43 Jun 24

Zim Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
127.87
+6.08 (+4.99%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Zim Laboratories Ltd. Financials

Zim Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
127.87
+6.08 (+4.99%)
15:43 Jun 24
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

74/100
Technically Bullish

Strength

9

Weakness

14

Opportunity

0

Threats

0

1.97 %

ROE %

1.08 %

ROA %

1.09

EPS

55.36

BVPS

1.55 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
333.43 398.53 367.42 379.03 374.4
Operating Expenses +
292.45 346.54 326.1 335.31 344.39
Raw Material
170.02 182.37 185.5 166.58 171.52
Increase Decrease in Cost
-9.67 16.46 -14.05 1.27 -6.14
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
40.07 49.32 53.34 60.76 63.9
Miscellaneous Expenses
110.85 133.17 116.91 129.86 130.05
Operating Profit
40.98 51.99 41.32 43.72 30.01
Other Income
4.4 6.41 5.18 5.78 11.38
Depreciation
16.03 17.47 15.95 20.11 19.98
Interest
8.31 5.58 6.92 11.39 13.2
Profit before tax and exceptio..
21.04 35.36 23.64 18.01 8.21
Exceptional Items
0 0 0 0 0
PBT
21.04 35.36 23.64 18.01 8.21
Provision for Taxation
6.49 10.92 6.4 5.84 2.37
Net Profit
14.55 24.43 17.25 12.16 5.84
NET Profit after MI
14.55 24.43 17.25 12.17 5.84
EPS
8.96 5.01 3.54 2.5 1.19
Operating Profit Margin (%)
12.29 13.05 11.25 11.53 8.02
Net Profit Margin (%)
4.36 6.13 4.69 3.21 1.56

Zim Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 30.40 33.30 33.30 33.30 33.30 33.30
FII 0.00 0.00 0.00 0.00 0.00 0.20
Public 0.10 0.20 0.20 0.30 0.20 0.20
Others 69.50 66.50 66.50 66.40 66.50 66.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: